SK Bioscience’s stock price is on the rise.
According to the Korea Exchange on the 28th, as of 1:36 pm, SK Bioscience is trading at 242,000 won, up 5.68% (13,000 won) from the previous day.
SK Bioscience’s market capitalization is 18.513 trillion won, ranking 22nd on the KOSPI. The par value is 500 won per share.
SK Bioscience’s stock price is strong on the news that Novavax applied for approval of a new coronavirus infection (COVID-19) vaccine to the UK health authorities the day before.
Novavax applied for approval in a clinical trial with 15,000 people in the UK saying it was 96.4% effective, and plans to apply for approval in the US soon.
© ‘Global Economic Daily in 5 Languages’ Aju Economic Daily. Unauthorized reproduction and redistribution prohibited